The role of Pleckstrin-2 as a functional node in myeloid proliferation
The role of Pleckstrin-2 as a functional node in myeloid proliferation
批准号:
10208952
负责人:
Peng Ji
金额:
$48.59万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-09 至 2024-06-30
关键词:
Acute Myelocytic LeukemiaAnemiaBindingBinding ProteinsBiochemicalBiological AssayBlood Cell CountBlood CellsBlood VesselsBlood coagulationBone Marrow DiseasesBone Marrow TransplantationCellsClinical TrialsComplexDataDevelopmentDrug resistanceErythropoietinFDA approvedFoundationsFundingFutureGoalsHematopoiesisHematopoieticHemorrhagic ThrombocythemiaIn VitroInfiltrationInjectionsJAK2 geneKnock-inKnock-in MouseKnock-outKnockout MiceLeadMembraneModelingMolecularMusMutationMyelogenousMyeloid CellsMyeloproliferationMyeloproliferative diseaseNamesNeutrophiliaPathogenesisPathway interactionsPatientsPharmaceutical ChemistryPhenotypePhiladelphia ChromosomePhosphatidylinositolsPhosphorylationPolycythemia VeraPrimary MyelofibrosisProductionProtein DephosphorylationPublishingReticulocytosisRiskRoleSamplingScaffolding ProteinSignal TransductionSpleenSplenomegalyStat5 proteinTestingTherapeuticThrombocytopeniaThrombosisToxic effectWorkbasedriver mutationeffective therapygenetic approachhigh throughput screeningin silicoin vivoin vivo Modelinhibitor/antagonistinsightmouse geneticsmouse modelnew therapeutic targetnovelnovel strategiesnovel therapeutic interventionoverexpressionphosphatidylinositol 3,4,5-triphosphateplatelet protein P47pre-clinicalrecruitside effectsmall molecule inhibitorthrombocytosistransplant model
中文摘要
项目摘要
骨髓增生性肿瘤(MPN)是一组骨髓疾病,
产生血栓形成和发展为急性髓性白血病的风险增加。v617F
JAK2的驱动突变是MPN的主要原因之一。这种突变的发现导致了
开发JAK抑制剂以治疗MPN。然而,JAK抑制剂不是治愈性的。此外,MPN
用JAK抑制剂治疗的患者通常由于JAK抑制剂的毒性而产生耐药性和严重的副作用。
JAK2在正常造血中的重要作用。我们一直在研究治疗MPN的新方法,
特别是关注JAK2通路的下游效应子。我们最近发表的研究
通过电流R01揭示了Pleckstrin-2(Plek2)的缺失,其是JAK2-STAT 5通路的新靶点,
改善JAK2V617F诱导的骨髓增殖表型,更重要的是逆转血管生成,
图10显示了JAK2V617F MPN小鼠模型的闭塞和致死率。鉴于Plek2在MPN中的重要性,
发病机制,我们已经确定了Plek2小分子抑制剂的先导化合物,使用基于硅的高,
通量筛选和基于细胞的测定。我们新的未发表的初步数据进一步揭示了Plek 2
Plek2与几种PI3K效应物结合,Plek2的缺失降低Akt活化。初步的体内证据也
表明Plek2对于PI3K-Akt通路是关键的,因为Plek2敲除改善了PI3K-Akt通路。
骨髓增殖和显着延长Pten造血特异性敲除小鼠的生存。这些
研究结果使我们假设Plek2作为一个中心枢纽连接JAK2-STAT和PI3K-
Akt通路并促进骨髓增生。为了验证这一假设,并研究其机制,
Plek2的功能,我们将使用1)体外生物化学和分子研究,以确定Plek2如何增强
PI3K-Akt信号通路; 2)Pten造血特异性敲除小鼠模型,以揭示Plek2的功能
体内,和3)临床前MPN模型和MPN患者样品,以确定Plek2抑制剂的功效。
该项目的成功完成将导致对Plek 2在糖尿病发病机制中的作用的新见解。
MPN,并为使用Plek2抑制剂作为单药或与
治疗MPN的其他化合物。
英文摘要
PROJECT SUMMARY
Myeloproliferative neoplasms (MPNs) are a group of bone marrow diseases that show excessive myeloid cell
production with an increased risk of developing thrombosis and evolving to acute myeloid leukemia. V617F
driver mutation of JAK2 is one of the leading causes of MPNs. The discovery of this mutation led to the
development of JAK inhibitors to treat MPNs. However, JAK inhibitors are not curative. In addition, MPN
patients treated with JAK inhibitor often develop drug resistance and severe side effects due to the
indispensable roles of JAK2 in normal hematopoiesis. We have been studying new approaches to treat MPNs,
especially focusing on the downstream effectors of the JAK2 pathway. Our recently published studies funded
by the current R01 revealed that loss of Pleckstrin-2 (Plek2), a novel target of the JAK2-STAT5 pathway,
ameliorated JAK2V617F-induced myeloproliferative phenotypes, and more importantly reverted vascular
occlusions and lethality of the JAK2V617F MPN mouse model. Given the significance of Plek2 in MPN
pathogenesis, we have identified lead compounds of Plek2 small molecule inhibitors using in silico-based high-
throughput screenings and cell-based assays. Our novel unpublished preliminary data further reveal that Plek2
binds to several PI3K effectors and loss of Plek2 reduces Akt activation. Preliminary in vivo evidence also
demonstrates that Plek2 is critical for the PI3K-Akt pathway in that Plek2 knockout ameliorated
myeloproliferation and significantly extended the survival of Pten hematopoietic specific knockout mice. These
findings lead us to hypothesize that Plek2 functions as a central hub to connect the JAK2-STAT and the PI3K-
Akt pathways and promote myeloproliferation. To test this hypothesis and investigate the mechanism of
function of Plek2, we will use 1) in vitro biochemical and molecular studies to determine how Plek2 enhances
the PI3K-Akt signaling, 2) Pten hematopoietic specific knockout mouse model to reveal the functions of Plek2
in vivo, and 3) pre-clinical MPN models and MPN patient samples to establish the efficacy of Plek2 inhibitors.
Successful completion of this project will lead to novel insights into the role of Plek2 in the pathogenesis of
MPNs and lay the foundation for clinical trials using Plek2 inhibitors as single agents or in combination with
other compounds to treat MPNs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting gasdermin D to treat myelodysplastic syndromes
-
批准号:10718497
-
项目类别:
-
资助金额:$53.88万
-
财政年份:2023
-
负责人:Peng Ji
-
依托单位:
The roles of mDia2 in membrane remodeling and organelle clearance during reticulocyte formation
-
批准号:10372107
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2020
-
负责人:Peng Ji
-
依托单位:
The role of Pleckstrin-2 as a functional node in myeloid proliferation
-
批准号:10432069
-
项目类别:
-
资助金额:$48.68万
-
财政年份:2020
-
负责人:Peng Ji
-
依托单位:
The roles of mDia2 in hematopoietic stem and progenitor cell engraftment and migration
-
批准号:10591568
-
项目类别:
-
资助金额:$50.69万
-
财政年份:2020
-
负责人:Peng Ji
-
依托单位:
The roles of mDia2 in membrane remodeling and organelle clearance during reticulocyte formation
-
批准号:10597618
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2020
-
负责人:Peng Ji
-
依托单位:
The roles of mDia2 in hematopoietic stem and progenitor cell engraftment and migration
-
批准号:10377496
-
项目类别:
-
资助金额:$50.69万
-
财政年份:2020
-
负责人:Peng Ji
-
依托单位:
The role of Pleckstrin-2 as a functional node in myeloid proliferation
-
批准号:10650349
-
项目类别:
-
资助金额:$48.68万
-
财政年份:2020
-
负责人:Peng Ji
-
依托单位:
The roles of pleckstrin-2 as a functional node in erythropoiesis
-
批准号:8884252
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2015
-
负责人:Peng Ji
-
依托单位:
The roles of pleckstrin-2 as a functional node in erythropoiesis
-
批准号:9052762
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2015
-
负责人:Peng Ji
-
依托单位:
Analysis of mDia formins in hematopoietic stem cell engraftment and migration
-
批准号:7872318
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2010
-
负责人:Peng Ji
-
依托单位:
Analysis of mDia formins in hematopoietic stem cell engraftment and migration
-
批准号:8532962
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2010
-
负责人:Peng Ji
-
依托单位:
Analysis of mDia formins in hematopoietic stem cell engraftment and migration
-
批准号:8484940
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Peng Ji
-
依托单位:
Analysis of mDia formins in hematopoietic stem cell engraftment and migration
-
批准号:8669055
-
项目类别:
-
资助金额:$23.91万
-
财政年份:2010
-
负责人:Peng Ji
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: